On the 10th of December 2021, ContextVision AB held an Extraordinary General Meeting in Stockholm.
- The Board’s proposal for a resolution on dividend of all shares in the Company’s wholly-owned subsidiary INIFY Laboratories AB containing the line of business Digital Pathology to the shareholders of ContextVision AB, was approved.
- No other matters were processed at the meeting.
Minutes of the meeting are attached hereto and will also be available on ContextVisions’ website www.contextvision.com
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.